Liver disease in patients with diabetes mellitus
- PMID: 7267479
- PMCID: PMC2426042
- DOI: 10.1136/pgmj.56.661.767
Liver disease in patients with diabetes mellitus
Abstract
Liver function tests were assessed in 60 unselected out-patient diabetics stabilized on insulin or oral hypoglycaemic agents. Routine liver function tests, particularly plasma concentrations of gamma-glutamyl transpeptidase and alkaline phosphatase were elevated occasionally but rarely to more than twice the upper limit of normal. There was no correlation between measures of diabetic control and results of liver function tests. Twelve (20%) patients had evidence of gall stones, a prevalence above the expected from the community. Fourteen (23%) patients had an abnormally bright liver ultrasound echo pattern, probably indicative of fatty infiltration of the liver. This echo pattern was associated with only a minimal rise in plasma alanine amino transferase and alkaline phosphatase concentrations. It is concluded that functionally significant liver disease is uncommon amongst stabilized diabetic patients.
Similar articles
-
Liver function tests in diabetic patients.Diabetes Care. 1984 May-Jun;7(3):248-54. doi: 10.2337/diacare.7.3.248. Diabetes Care. 1984. PMID: 6734394
-
Cross-sectional pilot study about the liver enzymes profile in type 2 diabetic patients from an Algerian west region: Wilaya of Mostaganem.Diabetes Metab Syndr. 2016 Jan-Mar;10(1 Suppl 1):S147-50. doi: 10.1016/j.dsx.2015.10.013. Epub 2015 Nov 12. Diabetes Metab Syndr. 2016. PMID: 26711007
-
Dulaglutide decreases plasma aminotransferases in people with Type 2 diabetes in a pattern consistent with liver fat reduction: a post hoc analysis of the AWARD programme.Diabet Med. 2018 Oct;35(10):1434-1439. doi: 10.1111/dme.13697. Epub 2018 Jun 22. Diabet Med. 2018. PMID: 29869810
-
Insulin and oral hypoglycaemic agents. II. Clinical and therapeutic aspects.Drugs. 1972;3(3):204-26. doi: 10.2165/00003495-197203030-00003. Drugs. 1972. PMID: 4561637 Review. No abstract available.
-
Liver disturbances in obesity and diabetes mellitus.Int J Obes Relat Metab Disord. 1995 Sep;19 Suppl 3:S27-36. Int J Obes Relat Metab Disord. 1995. PMID: 8581074 Review.
Cited by
-
Can probiotic, prebiotic, and synbiotic supplementation modulate the gut-liver axis in type 2 diabetes? A narrative and systematic review of clinical trials.Front Nutr. 2022 Dec 1;9:1052619. doi: 10.3389/fnut.2022.1052619. eCollection 2022. Front Nutr. 2022. PMID: 36532552 Free PMC article.
-
Can Bone-Specific Alkaline Phosphatase be a Marker of Vascular Calcification in Type 2 Diabetes Mellitus?Indian J Endocrinol Metab. 2023 Mar-Apr;27(2):127-132. doi: 10.4103/ijem.ijem_418_22. Epub 2023 Apr 14. Indian J Endocrinol Metab. 2023. PMID: 37292071 Free PMC article.
-
Visceral fat thickness predicts fatty liver in Koreans with type 2 diabetes mellitus.J Korean Med Sci. 2008 Apr;23(2):256-61. doi: 10.3346/jkms.2008.23.2.256. J Korean Med Sci. 2008. PMID: 18437009 Free PMC article.
-
The effects of diabetes mellitus on pharmacokinetics and pharmacodynamics in humans.Clin Pharmacokinet. 1991 Jun;20(6):477-90. doi: 10.2165/00003088-199120060-00004. Clin Pharmacokinet. 1991. PMID: 2044331 Review.
-
Steatosis recovery after treatment with a balanced sunflower or olive oil-based diet: involvement of perisinusoidal stellate cells.World J Gastroenterol. 2005 Dec 21;11(47):7480-5. doi: 10.3748/wjg.v11.i47.7480. World J Gastroenterol. 2005. PMID: 16437720 Free PMC article.
References
MeSH terms
LinkOut - more resources
Full Text Sources
Medical